This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Hitachi Echelon Oval (Photo: Business Wire)

Hitachi Medical Systems America, Inc., a leading provider of diagnostic imaging equipment, announced FDA clearance to market its Echelon Oval 1.5T Ultra-Wide MR system.

Hitachi Echelon Oval (Photo: Business Wire)

Hitachi Echelon Oval (Photo: Business Wire)

Echelon Oval sets a new standard for premium wide bore 1.5T MRI with its patient shaped design, resulting in a 74 cm oval bore – the widest in the industry.

“With the evolving changes in health care delivery putting ever more emphasis on patient comfort and satisfaction, Echelon Oval re-shapes expectations for MR imaging,” said Sheldon Schaffer, Vice President and General Manager, MR and CT.

The latest innovation from Hitachi addresses the important aspects of patient accessibility, broad range of clinical capability and optimized workflow. All patients, particularly claustrophobic and anxious ones, will benefit from increased space and visibility. With a diverse suite of advanced imaging techniques including non-contrast MRA, isotropic image acquisition, robust fat suppression and much more, Echelon Oval delivers high diagnostic confidence. In addition, Hitachi’s Workflow Integrated Technology (WIT) suite of efficiency-focused and patient-friendly features, such as an integrated coil system and wide mobile table, optimize the entire imaging process.

“For over two decades Hitachi has lead the way in innovative, reliable MR products that have always put the comfort of the patient first,” Schaffer added. “Echelon Oval joins a storied progression of MR products that deliver state-of-the-art imaging capability, without sacrificing patient comfort.’”

About Hitachi Medical Systems America, Inc. Hitachi Medical Systems America (HMSA) located in Twinsburg, Ohio, a wholly owned subsidiary of Hitachi Medical Corporation, offers a broad range of diagnostic imaging equipment including MRI, CT and Ultrasound. Our innovations in diagnostic imaging provide technology that drives clinical solutions to deliver diagnostic confidence, improve workflow efficiency and provide a better patient experience. In addition to exceptional equipment, HMSA is known for its comprehensive customer support programs to maximize the lifecycle value of equipment through responsive service maintenance, significant software upgrades and on-going applications support.

About Hitachi, Ltd. Hitachi, Ltd., (NYSE: HIT) (TOKYO: 6501), headquartered in Tokyo, Japan, is a leading global electronics company with approximately 362,000 employees worldwide on the consolidated basis. Fiscal 2010 (ended March 31, 2011) consolidated revenues totaled 9,316 billion yen ($110.9 billion). Hitachi will focus more than ever on the Social Innovation Business, which includes Information and Telecommunication Systems, Power Systems, Industrial, Transportation and Urban Development Systems, as well as the sophisticated Materials and Key Devices that support them.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50270232&lang=en

Copyright Business Wire 2010

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,985.61 +78.99 0.47%
S&P 500 1,972.83 +9.12 0.46%
NASDAQ 4,419.0340 +27.5710 0.63%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs